首页> 外文学位 >Antiviral agents from selected Chinese herbal medicines.
【24h】

Antiviral agents from selected Chinese herbal medicines.

机译:精选中草药的抗病毒剂。

获取原文
获取原文并翻译 | 示例

摘要

Human viral infections are important health problem worldwide. Although much effort has been made, antiviral drugs, because of the unique properties of viruses, are relatively fewer in number and possess relatively narrow spectrum of activities as compared with antibiotics. Moreover, efficacy, drug resistance and side effect are the problems of antiviral drugs in clinical uses. Thus, it is necessary to develop new, effective and safe antiviral drug.;Traditional herbal medicines have been used for a long time in the treatment of human infectious diseases in many countries, including China. Antiviral screening has shown that quite a few medicinal herbs distributed in various regions of the world possess significant antiviral activities with no or limited adverse effects, and many naturally occurring compounds exhibit antiviral activity in vitro and/or in vivo. In the present study, our objectives are to (1) screen for potential antiviral agents from selected herbal medicines traditionally used in southern China, (2) isolate and characterize the antiviral constituents from the most active herb, and (3) probe possible antiviral modes of action of the active compounds. The viruses used in the present study included respiratory syncytial virus (RSV), herpes simplex virus type 1 (HSV-1), influenza A virus (Flu A), and coxsackie B3 virus (Cox B3). However, the present study mainly focused on searching for anti-RSV and anti-HSV-1 agents from selected Chinese herbal medicines.;Thirty-seven medicinal herbs, which were collected from Guangdong province or the Hong Kong region, were selected to screen for their antiviral activities against HSV-1 and/or RSV in vitro using a cytopathic effect (CPE) reduction assay. The selection of the herbs was mainly based on their traditional use in the treatment of human infectious diseases of the skin and respiratory tract.;Three of 37 medicinal herbs, Agrimonia pilosa, Pithecellobium clypearia, and Punica granatum, showed anti-HSV-1 activity, which was possibly contributed from polyphenolic compounds in the herbal extracts. Six of 21 medicinal herbs, Blumea laciniata, Elephantopus scaber, Laggera pterodonta, Mussaenda pubescens, Schefflera heptaphylla, and Scutellaria indica, exhibited potent anti-RSV activity with 50% inhibition concentrations (IC50) ranging from 12.5 to 32 mug/ml, and the selective indices (SI) ranging from 11.2 to 40. Moreover, the anti-RSV SI values of Laggera pterodonta and Schefflera heptaphylla were found to be higher than that of ribavirin. Finally, Schefflera heptaphylla having the highest anti-RSV SI value among the active herbs was subjected to further study its antiviral activity. (Abstract shortened by UMI.).
机译:人类病毒感染是全世界重要的健康问题。尽管已作了大量努力,但由于抗病毒药的独特性质,与抗生素相比,抗病毒药的数量相对较少,并且具有相对窄的活性谱。而且,功效,耐药性和副作用是临床应用中抗病毒药物的问题。因此,有必要开发一种新的,有效的,安全的抗病毒药物。传统草药在包括中国在内的许多国家已被长期用于人类感染性疾病的治疗。抗病毒筛选表明,分布在世界各地的相当多的草药具有显着的抗病毒活性,而没有或仅有有限的副作用,并且许多天然存在的化合物在体外和/或体内均表现出抗病毒活性。在本研究中,我们的目标是(1)从中国南方传统使用的精选草药中筛选潜在的抗病毒药,(2)从活性最高的草药中分离和鉴定抗病毒成分,(3)探索可能的抗病毒方式活性化合物的作用。本研究中使用的病毒包括呼吸道合胞病毒(RSV),1型单纯疱疹病毒(HSV-1),甲型流感病毒(Flu A)和柯萨奇B3病毒(Cox B3)。然而,本研究主要集中在从所选中草药中寻找抗RSV和抗HSV-1药物。选择了从广东省或香港地区收集的37种草药进行筛选使用细胞病变效应(CPE)降低检测技术检测它们在体外对HSV-1和/或RSV的抗病毒活性。草药的选择主要是基于其在皮肤和呼吸道人类感染性疾病治疗中的传统用途。; 37种草药中的三种,即龙牙草,茶皮草和石榴,具有抗HSV-1活性。 ,可能是由草药提取物中的多酚类化合物引起的。 21种药材中的6种,Blumea laciniata,Elephantopus scaber,Laggera pterodonta,Mussaenda pubescens,Schefflera heptaphylla和Indica Scutellaria均表现出强大的抗RSV活性,其50%抑制浓度(IC50)在12.5至32杯/毫升之间,并且选择性指数(SI)的范围是11.2至40。此外,发现翼状藻(Laggera pterodonta)和七叶鹅掌Sch(Schefflera heptaphylla)的抗RSV SI值高于利巴韦林。最后,对活性成分中具有最高抗RSV SI值的七叶鹅肝进行了进一步的研究。 (摘要由UMI缩短。)。

著录项

  • 作者

    Li, Yaolan.;

  • 作者单位

    The Chinese University of Hong Kong (Hong Kong).;

  • 授予单位 The Chinese University of Hong Kong (Hong Kong).;
  • 学科 Biology Cell.;Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 2005
  • 页码 201 p.
  • 总页数 201
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:42:50

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号